Image is an illustration, may not reflect the exact product sold.


Other products by Merck

Merck - 71346-4 - Origami 2(DE3)pLysS Competent Cells - Novagen

  • MFR SKU: 71346-4
  • ITEM #: 5010531
  • 0 Reviews / 0 Questions
$371.72
Stock Status: SHIPS SOON (reserve your unit today)
Average lead time for this brand: 2-3 weeks. Specific products may vary.

ITEM #: 5010531
Origami 2 strains have mutations in glutathione reducatase(gor) and thioredoxin reductase (trxB), facilitating proper disulfide bond formation. T7 lysozyme expression suppresses basal T7 expression.
This listing is for 1 ml Glass bottle

Merck - 71346-4 - Origami 2(DE3)pLysS Competent Cells - Novagen

  • Item #: 5010531
  • MFR SKU: 71346-4
  • Overview Origami™ 2 host strains are K-12 derivatives that have mutations in both the thioredoxin reductase ( trxB ) and glutathione reductase ( gor ) genes, which greatly enhance disulfide bond formation in the E. coli cytoplasm. The Origami 2 strains are kanamycin sensitive; like the original Origami strains, the gor mutation is still selected for by tetracycline. To reduce the possibility of disulfide bond formation between molecules, strains containing mutations in trxB and gor are recommended only for the expression of proteins that require disulfide bond formation for proper folding.
  • DE3 indicates that the host is a lysogen of λ DE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene under control of the lacUV5 promoter. Such strains are suitable for production of protein from target genes cloned in pET vectors by induction with IPTG.
  • pLysS strains express T7 lysozyme, which further suppresses basal expression of T7 RNA polymerase prior to induction, thus stabilizing pET recombinants encoding target proteins that affect cell growth and viability.
  • Genotype: Δ(ara-leu)7697 ΔlacX74 ΔphoA Pvu II phoR araD139 ahpC galE galK rpsL F′[ lac + lacI q pro ] (DE3) gor522 ::Tn 10 trxB pLysS (Cam R , Str R , Tet R )
  • This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
  • This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@ .
  • Catalogue Number 71346
  • Brand Family Novagen®
  • 0.4 ml 1 ml Component
  • • 2 × 0.2 ml 5 × 0.2 ml Origami™ 2(DE3)pLysS Competent Cells
  • • 2 × 2 ml 4 × 2 ml SOC Medium
  • • 2 ng 2 ng Test Plasmid
  • Guaranteed efficiency 2 × 10 cfu/µg
  • Quality Level MQ100
  • Ship Code Dry Ice Only
  • Toxicity Multiple Toxicity Values, refer to MSDS
  • Storage ≤ -70° C
  • Do not freeze Ok to freeze

There are no questions about this product yet. Be the first to ask a question.

0 out of 5 stars
5 Star
0 %
4 Star
0 %
3 Star
0 %
2 Star
0 %
1 Star
0 %

Review this product

Tell us about your personal experience

Recently Viewed Items